Targeting the ARL4C/RAP1/PI3K-Akt-mTOR signaling loop promotes ARL4C ubiquitination and reverses oxaliplatin resistance in colorectal cancer
Theranostics · 01.01.2026 · 16 (1) · 99-122
DOI: 10.7150/thno.117590 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, erschienen am 01.01.2026. Verfasst von Yang Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal Oncology Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Oxaliplatin, Drug Resistance, Neoplasm, ADP-Ribosylation Factors. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Colorectal Oncology Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- Heilongjiang Province Key Laboratory of Digestive Surgery and Nutrition & Metabolism, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
- Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Zitieren
APA
Wang, Y., Chang, Z., Sun, Z., Wang, L., Li, J., Li, G., Wang, Y., Zhang, J., Ai, L., Zhang, Z., Dong, J., & Liu, M. (2026). Targeting the ARL4C/RAP1/PI3K-Akt-mTOR signaling loop promotes ARL4C ubiquitination and reverses oxaliplatin resistance in colorectal cancer. Theranostics, 16(1), 99-122. https://doi.org/10.7150/thno.117590
Vancouver
Wang Y, Chang Z, Sun Z, Wang L, Li J, Li G, et al. Targeting the ARL4C/RAP1/PI3K-Akt-mTOR signaling loop promotes ARL4C ubiquitination and reverses oxaliplatin resistance in colorectal cancer. Theranostics. 2026;16(1):99-122. doi:10.7150/thno.117590
BibTeX
@article{Wang2026,
author = {Wang, Yang and Chang, Zewen and Sun, Ziquan and Wang, Lu and Li, Jingtao and Li, Guodong and Wang, Yuliuming and Zhang, Jinning and Ai, Lianjie and Zhang, Zhongxu and Dong, Jiaojiao and Liu, Ming},
title = {Targeting the ARL4C/RAP1/PI3K-Akt-mTOR signaling loop promotes ARL4C ubiquitination and reverses oxaliplatin resistance in colorectal cancer},
journal = {Theranostics},
year = {2026},
volume = {16},
number = {1},
pages = {99--122},
doi = {10.7150/thno.117590}
}
EUVIMED